Premium
Staging classification for cancer of the ovary, fallopian tube, and peritoneum
Author(s) -
Prat Jaime
Publication year - 2014
Publication title -
international journal of gynecology and obstetrics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.895
H-Index - 97
eISSN - 1879-3479
pISSN - 0020-7292
DOI - 10.1016/j.ijgo.2013.10.001
Subject(s) - medicine , fallopian tube , peritoneum , ovary , ovarian cancer , gynecology , cancer , anatomy
Ovarian cancer is the seventh most common cancer diagnosis amongwomenworldwide, and thefifthmost common cancer diagnosis among women in higher-resource regions [1]. The world rate is estimated to be 6.3 per 100 000 women, and is highest in highresource countries (9.3 per 100 000 women) [1]. Primary peritoneal cancer and primary fallopian tube cancer are rare malignancies but share many similarities with ovarian cancer. Clinically, these 3 cancers are managed in a similar manner [2]. The main purpose of staging systems is 2-fold: to provide standard terminology that allows comparison of patients between centers; and to assign patients and their tumors to prognostic groups requiring specific treatments. Ovarian cancer is staged surgically and pathologically, and the last revision of the FIGO staging classification was made in 1988 (Rio de Janeiro). The FIGO Committee on Gynecologic Oncology feels that it is time to revise this classification to improve utility and reproducibility. Cancer staging evolves continuously as scientific developments occur, diagnostic methods improve, and more accurate prognostic information becomes available. Over the past quarter of a century, several scientific developments have challenged traditional concepts in ovarian cancer. Initially, it was recognized that ovarian cancer is not a homogeneous disease, but rather a group of diseases— each with different morphology and biological behavior. Approximately 90% of ovarian cancers are carcinomas (malignant epithelial tumors)